Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AIM Act Touted As One Solution To Device Reimbursement Woes

This article was originally published in The Gray Sheet

Executive Summary

The Accelerating Innovation in Medicine Act, introduced last year with some bipartisan support, was touted at the latest House 21st Century Cures hearing as a self-pay path for seniors to get access to newly-approved devices not yet covered under Medicare, and to give manufacturers time to collect needed data to support reimbursement.


Related Content

Shortened ‘Cures’ Draft Retains Breakthrough Pathway, Device Reforms
Device Industry Grab-Bag Of Provisions In 21st Century Cures Draft
Device Consortium Addresses Barriers To Early U.S. Feasibility Studies, MDIC’s Murray Tells Congress
Lawmakers Want HIPAA Data Access Rules Amended To Encourage Consumer ‘Shopping’ For Diagnostics
Shuren Highlights CDRH Actions To Ease Trial Burdens On Capitol Hill
CDRH Focusing On New PMA Pathway, Clinical Trials Program In 2014/2015 Priorities





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts